Thomas Muley Selected Research

Thomas Muley Research Topics

Disease

76	Neoplasms (Cancer) 04/2024 - 03/2002
59	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2005
34	Lung Neoplasms (Lung Cancer) 03/2024 - 01/2005
17	Adenocarcinoma 12/2023 - 01/2005
17	Adenocarcinoma of Lung 09/2022 - 11/2008
14	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2023 - 01/2005
10	Neoplasm Metastasis (Metastasis) 03/2020 - 09/2003
9	Disease Progression 04/2024 - 12/2019
7	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2023 - 03/2002
6	Inflammation (Inflammations) 01/2022 - 01/2013
4	Carcinoma (Carcinomatosis) 12/2020 - 03/2013
4	Lung Diseases (Lung Disease) 01/2020 - 05/2010
4	Malignant Mesothelioma 11/2016 - 11/2008
3	Mesothelioma 04/2024 - 05/2012
3	Lymphatic Metastasis 01/2018 - 09/2003
3	Sarcoma (Soft Tissue Sarcoma) 03/2014 - 01/2012
2	Sarcopenia 10/2021 - 01/2017
2	Carcinogenesis 01/2021 - 01/2020
2	Clinical Deterioration 01/2021 - 01/2021
2	Pneumonia (Pneumonitis) 01/2021 - 01/2020
2	Fibrosis (Cirrhosis) 01/2021 - 01/2020
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2021 - 01/2020
2	Hypoxia (Hypoxemia) 12/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 10/2016
2	Breast Neoplasms (Breast Cancer) 07/2012 - 12/2011
2	Thymoma (Thymic Carcinoma) 10/2009 - 04/2007
1	Neuroendocrine Carcinoma 02/2024

Drug/Important Bio-Agent (IBA)

21	Biomarkers (Surrogate Marker)IBA 04/2024 - 05/2012
20	Proteins (Proteins, Gene)FDA Link 03/2024 - 11/2008
9	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2007
8	DNA (Deoxyribonucleic Acid)IBA 12/2022 - 11/2008
7	RNA (Ribonucleic Acid)IBA 11/2023 - 11/2006
6	Tumor Biomarkers (Tumor Markers)IBA 10/2023 - 05/2004
6	Tyrosine Kinase InhibitorsIBA 12/2022 - 07/2012
5	GlycodelinIBA 03/2024 - 08/2015
5	MicroRNAs (MicroRNA)IBA 03/2022 - 03/2013
4	antigen CYFRA21.1IBA 10/2023 - 06/2008
4	Cell-Free Nucleic AcidsIBA 12/2022 - 01/2016
4	Immune Checkpoint InhibitorsIBA 03/2022 - 08/2020
4	AntigensIBA 11/2020 - 12/2011
4	Keratin-19 (Keratin 19)IBA 01/2019 - 01/2005
4	Carcinoembryonic AntigenIBA 01/2018 - 09/2003
4	MesothelinIBA 11/2016 - 11/2008
4	Phosphopyruvate Hydratase (Enolase)IBA 03/2015 - 03/2002
3	Glycoproteins (Glycoprotein)IBA 03/2024 - 08/2015
3	Transcription Factors (Transcription Factor)IBA 02/2024 - 03/2014
3	B7-H1 AntigenIBA 12/2023 - 01/2018
3	C-Reactive ProteinIBA 01/2022 - 12/2017
3	SynaptophysinIBA 05/2021 - 03/2015
3	Peptides (Polypeptides)IBA 09/2020 - 07/2013
3	Anaplastic Lymphoma KinaseIBA 12/2019 - 03/2014
3	ElementsIBA 01/2019 - 03/2009
3	EnzymesIBA 03/2016 - 01/2003
2	pro-gastrin-releasing peptide (31-98)IBA 10/2023 - 09/2020
2	Complement System Proteins (Complement)IBA 10/2023 - 01/2022
2	Etoposide (VP 16)FDA LinkGeneric 09/2022 - 03/2020
2	Messenger RNA (mRNA)IBA 09/2022 - 08/2015
2	AlbuminsIBA 01/2022 - 12/2017
2	durvalumabIBA 01/2021 - 01/2020
2	Carrier Proteins (Binding Protein)IBA 12/2020 - 11/2015
2	PlatinumIBA 03/2020 - 01/2020
2	Chromogranin AIBA 01/2020 - 03/2015
2	Long Noncoding RNAIBA 01/2020 - 01/2018
2	Blood Proteins (Serum Proteins)IBA 12/2019 - 01/2014
2	IronIBA 01/2019 - 01/2017
2	ParaffinIBA 01/2019 - 05/2016
2	LigandsIBA 01/2018 - 06/2012
2	AntibodiesIBA 01/2018 - 08/2010
2	Phospholipids (Phosphatides)FDA LinkGeneric 03/2016 - 10/2015
2	Phosphotransferases (Kinase)IBA 02/2013 - 08/2006
2	Amino Acids FDA Link 01/2013 - 04/2007
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2008 - 04/2007
1	Calbindin 2IBA 04/2024
1	Ribosomal RNAIBA 11/2023
1	Unithiol (DMPS)IBA 09/2022
1	Cisplatin (Platino)FDA LinkGeneric 09/2022
1	Circulating Tumor DNAIBA 05/2022
1	Serine Proteases (Serine Protease)IBA 04/2022
1	LuciferasesIBA 01/2022
1	HaptoglobinsIBA 01/2022
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2022
1	PlakophilinsIBA 01/2022
1	AcidsIBA 01/2022
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 01/2022
1	Ceruloplasmin (Ferroxidase)IBA 01/2022
1	ChromograninsIBA 05/2021
1	InterferonsIBA 01/2021
1	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 01/2021
1	Versicans (Versican)IBA 01/2021

Therapy/Procedure

43	Therapeutics 10/2023 - 03/2002
11	Drug Therapy (Chemotherapy) 10/2023 - 04/2007
6	Immunotherapy 03/2024 - 01/2019
5	Pneumonectomy (Lung Volume Reduction) 10/2021 - 11/2008
4	Radiotherapy 07/2019 - 12/2007
3	Adjuvant Chemotherapy 04/2024 - 01/2018
2	Combined Modality Therapy 04/2024 - 08/2015
2	Lasers (Laser) 10/2016 - 03/2013
2	Metastasectomy 12/2011 - 09/2003
1	Cytoreduction Surgical Procedures 04/2024
1	Traction 03/2022